SCHEMBL20908243

SCHEMBL20908243

CC(N)N1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL190387 0.93
Hydrochloric Acid SCHEMBL9031347 0.90 SMN1; SMN2 (0.32)
SCHEMBL633836 0.90
SCHEMBL476458 0.90 DPP7 (0.37)
SCHEMBL2412914 0.87
SCHEMBL7142061 0.86 CYP2D6 (0.32)
SCHEMBL20661653 0.86
SCHEMBL3416020 0.86
SCHEMBL179841 0.86 CYP2D6 (0.32)
SCHEMBL24971854 0.84 SMN1; SMN2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3873903-B1 SUBSTITUTED 6-AZABENZIMIDAZOLE COMPOUNDS AS HPK1 INHIBITORS GILEAD SCIENCES INC (US) 2024-01-24 EP disclosed
WO-2023141866-A1 PYRAZOLOPYRIMIDINES AS MODULATORS OF SPERMINE OXIDASE JANSSEN PHARMACEUTICA NV (BE) 2023-08-03 WO disclosed
US-10822370-B2 19-nor neuroactive steroids and methods of use thereof SAGE THERAPEUTICS, INC. (US) 2020-11-03 US disclosed
EP-3371168-B1 INDOLIN-2-ONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2020-05-27 EP disclosed
US-20190112331-A1 19-NOR NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF SAGE THERAPEUTICS, INC. 2019-04-18 US disclosed